Baxter Basic EPS 2010-2025 | BAX
Baxter annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Baxter basic eps for the quarter ending March 31, 2025 was $0.25, a 257.14% increase year-over-year.
- Baxter basic eps for the twelve months ending March 31, 2025 was $-1.09, a 120.84% decline year-over-year.
- Baxter annual basic eps for 2024 was $-0.001B, a 124.19% decline from 2023.
- Baxter annual basic eps for 2023 was $0.005B, a 208.7% decline from 2022.
- Baxter annual basic eps for 2022 was $-0.005B, a 288.67% decline from 2021.
| Baxter Annual Basic EPS |
| 2024 |
$-1.27 |
| 2023 |
$5.25 |
| 2022 |
$-4.83 |
| 2021 |
$2.56 |
| 2020 |
$2.17 |
| 2019 |
$1.97 |
| 2018 |
$2.90 |
| 2017 |
$1.11 |
| 2016 |
$9.09 |
| 2015 |
$1.78 |
| 2014 |
$4.61 |
| 2013 |
$3.70 |
| 2012 |
$4.22 |
| 2011 |
$3.91 |
| 2010 |
$2.41 |
| 2009 |
$3.63 |
| Baxter Quarterly Basic EPS |
| 2025-03-31 |
$0.25 |
| 2024-12-31 |
$-0.99 |
| 2024-09-30 |
$0.27 |
| 2024-06-30 |
$-0.62 |
| 2024-03-31 |
$0.07 |
| 2023-12-31 |
$0.49 |
| 2023-09-30 |
$4.95 |
| 2023-06-30 |
$-0.28 |
| 2023-03-31 |
$0.09 |
| 2022-12-31 |
$0.36 |
| 2022-09-30 |
$-5.83 |
| 2022-06-30 |
$0.50 |
| 2022-03-31 |
$0.14 |
| 2021-12-31 |
$0.48 |
| 2021-09-30 |
$0.90 |
| 2021-06-30 |
$0.59 |
| 2021-03-31 |
$0.59 |
| 2020-12-31 |
$0.34 |
| 2020-09-30 |
$0.70 |
| 2020-06-30 |
$0.48 |
| 2020-03-31 |
$0.65 |
| 2019-12-31 |
$-0.03 |
| 2019-09-30 |
$0.72 |
| 2019-06-30 |
$0.61 |
| 2019-03-31 |
$0.67 |
| 2018-12-31 |
$0.57 |
| 2018-09-30 |
$0.97 |
| 2018-06-30 |
$0.64 |
| 2018-03-31 |
$0.72 |
| 2017-12-31 |
$-0.34 |
| 2017-09-30 |
$0.46 |
| 2017-06-30 |
$0.49 |
| 2017-03-31 |
$0.50 |
| 2016-12-31 |
$0.48 |
| 2016-09-30 |
$0.24 |
| 2016-06-30 |
$2.21 |
| 2016-03-31 |
$6.16 |
| 2015-12-31 |
$0.37 |
| 2015-09-30 |
$0.00 |
| 2015-06-30 |
$0.61 |
| 2015-03-31 |
$0.79 |
| 2014-12-31 |
$1.76 |
| 2014-09-30 |
$0.86 |
| 2014-06-30 |
$0.96 |
| 2014-03-31 |
$1.02 |
| 2013-12-31 |
$0.60 |
| 2013-09-30 |
$1.00 |
| 2013-06-30 |
$1.09 |
| 2013-03-31 |
$1.01 |
| 2012-12-31 |
$0.90 |
| 2012-09-30 |
$1.07 |
| 2012-06-30 |
$1.20 |
| 2012-03-31 |
$1.05 |
| 2011-12-31 |
$0.82 |
| 2011-09-30 |
$1.02 |
| 2011-06-30 |
$1.08 |
| 2011-03-31 |
$0.99 |
| 2010-12-31 |
$0.72 |
| 2010-09-30 |
$0.90 |
| 2010-06-30 |
$0.90 |
| 2010-03-31 |
$-0.11 |
| 2009-12-31 |
$0.94 |
| 2009-09-30 |
$0.88 |
| 2009-06-30 |
$0.97 |
| 2009-03-31 |
$0.84 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$15.752B |
$10.636B |
|
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
|
